Search for: [Abstract = "n symptoms in patients with MPN and CML. In addition, the assessment of the relationship between age, sex, treatment duration, and the severity of individual factors of mental state in both groups of patients was examined. The predictors of the severity of somatization, depression, and anxiety symptoms were analyzed. The above results inspired the development of further analyses of the individual side effects of treatment with interferon\-alpha and tyrosine kinase inhibitors, as well as their possible impact on the intensity of depressive, anxiety, or somatization symptoms. The thesis consists of three research articles\: 1. Assessment of factors affecting the mental condition of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. 2. Side effects of treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia and the occurrence of anxiety symptoms. 3. Comparison of depressive, anxiety, and somatization symptoms in patients with Philadelphia negative chronic myeloproliferative neoplasms treated with interferon\-alpha. Methods\: The studies were carried out at the Hematology Clinic of the University Hospital \(SU\) in Kraków and the Clinic of Hematology, Blood Cancer and Bone Marrow Transplantation in Wrocław, involving 175 patients with myeloproliferative neoplasms \(91\- CML, 84 \- MPN\). The self\-questionnaire"]
